Neutrophil to lymphocyte ratio in immunotherapy for malignancies

In the quest for a simple and effective biomarker for PD-1 antibody efficacy many candidates have emerged. The simplest one is the ratio between neutrophils and lymphocytes (NLR) in peripheral blood. Since 2012 the emergence of checkpoint inhibitor therapy has introduced a new paradigm in cancer the...

Full description

Bibliographic Details
Main Author: Bassim Kobrossy
Format: Article
Language:English
Published: Bulgarian Association of Young Surgeons 2020-01-01
Series:International Journal of Medical Reviews and Case Reports
Subjects:
pd1
Online Access:http://www.mdpub.net/index.php?fulltxt=82035&fulltxtj=172&fulltxtp=172-1579034274.pdf